The Centers for Disease Control and Prevention issued new guidance Thursday recommending that TPoxx, the only drug available to treat monkeypox, be limited to people at high risk for severe disease even as the outbreak that has infected more than 22,000 Americans shows signs of plateauing.

https://www.washingtonpost.com/health/2022/09/15/monkeypox-tpoxx-antiviral-cdc/